Clinical study of the efficacy of low molecular weight sodium hyaluronate in complex treatment of corneal graft disease
https://doi.org/10.29235/1814-6023-2020-17-2-170-177
Abstract
The results of corneal graft disease treatment using low molecular weight sodium hyaluronate are presented.
The study included 19 patients (20 eyes) aged 24 to 87 years, who developed graft disease after keratoplasty because of chronic dystrophic corneal diseases. The severity of symptoms during treatment was evaluated weekly during the course of therapy using the OSDI (Ocular Surface Disease Index). To assess the dynamics of objective signs of Dry eye disease in dynamics, visometry, biomicroscopy, Schirmer’s test and LIPCOF test were performed weekly before the next injection. A follow-up study was carried out a week after the last injection, with a 1-year dynamic observation following the treatment.
Changes in objective indicators of the anterior eye surface were characterized by positive dynamics during therapy. The Schirmer test (p < 0.00001) increased most rapidly and significantly with a lasting effect for a month, demonstrating a beneficial therapeutic effect on both the aqueous and mucinous layer of the tear film. A decrease in the OSDI index was noted after the first injection and decreased progressively during the course of treatment and after its completion up to one month after the last injection (p < 0.00001).
About the Author
G. R. Semak
Belarusian State Medical University
Belarus
Belarus
Galina R. Semak – Ph. D. (Med.), Assistant Professor
83, Dzerzhinski Ave., 220116
References
1. Nelson J. D., Craig J. P., Akpek E. K., Azar D. T., Belmonte C., Bron A. J. [et al.]. TFOS DEWS II Introduction. The Ocular Surface, 2017, vol. 15, no. 3, pp. 269–275. https://doi.org/10.1016/j.jtos.2017.05.005
2. Maeno A., Naor J., Lee H. M., Hunter W. S., Rootman D. S. Three decades of comeal transplantation: indications and patient characteristics. Cornea, 2000, vol. 19, no. 1, рр. 7–11. https://doi.org/10.1097/00003226-200001000-00002
3. Birnbaum F., Mayweg S., Reis A., Böhringer D., Seitz B., Engelmann K., Messmer E. M., Reinhard T. Mycophenolate mofetil (MMF) following penetrating high-risk keratoplasty: long-term results of a prospective, randomised, multicentre study. Eye (Lond.), 2009, vol. 23, no. 11, рр. 2063–2070. https://doi.org/10.1038/eye.2008.402
4. Franzmann E. J., Schroeder G. L., Goodwin W. J., Weed D. T., Fisher P., Lokeshwar V. B. Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors. International Journal of Cancer, 2003, vol. 106, no. 3, рр. 438–445. https://doi.org/10.1002/ijc.11252
5. Lokeshwar V. B., Cerwinka W. H., Isoyama T., Lokeshwar B. L. HYAL1 yaluronidase in prostate cancer: a tumor promoter and suppressor. Cancer Research, 2005, vol. 65, no. 17, рр. 7782–7789. https://doi.org/10.1158/0008-5472.can-05-1022
6. Simpson M. A., Lokeshwar V. B. Hyaluronan and hyaluronidase in genitourinarytumors. Frontiers in Bioscience, 2008, vol. 13, рр. 5664–5680. https://doi.org/10.2741/3108
7. Eissa S., Shehata H., Mansour A., Esmat M., El-Ahmady O. Detection of hyaluronidase RNA and activity in urine of schistosomal and non-schistosomal bladder cancer. Medical Oncology, 2012, vol. 29, no. 5, рр. 3345–3351. https://doi.org/10.1007/s12032-012-0295-8
8. Yoffou P. H., Edjekouane L., Meunier L., Tremblay A., Provencher D. M., MesMasson A.-M., Carmona E. Subtype specific elevated expression of hyaluronidase-1 (HYAL-1) in epithelial ovarian cancer. PLoS ONE, 2011, vol. 6, no. 6, p. e20705. https://doi.org/10.1371/journal.pone.0020705
9. Nykopp T. K., Rilla K., Tammi M. I., Tammi R. H., Sironen R., Hämäläinen K., Kosma V.-M., Heinonen S., Anttila M. Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma. BMC Cancer, 2010, vol. 10, no. 1, art. 512. https://doi.org/10.1186/1471-2407-10-512
10. Salzillo R., Schiraldi C., Corsuto L., D’Agostino A., Filosa R., de Rosa M., la Gatta A. Optimization of hyaluronanbased eye drop formulations. Carbohydrate Polymers, 2016, vol. 153, рр. 275–283. https://doi.org/10.1016/j.carbpol.2016.07.106
Review
For citations:
Semak G.R. Clinical study of the efficacy of low molecular weight sodium hyaluronate in complex treatment of corneal graft disease. Proceedings of the National Academy of Sciences of Belarus, Medical series. 2020;17(2):170-177. https://doi.org/10.29235/1814-6023-2020-17-2-170-177
Views: 433
Email this article 